Breast Cancer Clinical Trial

Proton Therapy for Early Stage Breast Cancer

Summary

The purpose of this study is to determine if partial breast proton therapy is effective treatment for early stage breast cancer following lumpectomy.

View Full Description

Full Description

Radiation therapy is considered standard treatment for most women with early stage breast cancer following lumpectomy. Post-lumpectomy radiotherapy is a proven treatment that reduces cancer recurrence in the breast and improves survival. When standard whole breast radiation techniques are utilized, portions of the chest wall, lung and heart may also receive significant doses of radiation which can lead to radiation induced complications. Radiation techniques that limit the treatment area to the portion of the breast where the cancer arose can minimize and even eliminate radiation dose to the chest wall, heart and lung. This is called partial breast radiotherapy. This study is designed to evaluate the use of proton beam radiotherapy to deliver partial breast radiotherapy in women with early stage breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Invasive ductal, medullary, papillary, colloid or tubular histologies
Stages T1 or T2 (tumors < or = 3 cm) from lumpectomy specimen.
No more then 3 positive nodes on axillary dissection or negative sentinel node.
Negative surgical margins (>2mm)

Exclusion Criteria:

Invasive lobular histology
Previous chemotherapy for breast cancer
Extensive intraductal component
Collagen vascular disease
Prior malignancy unless disease-free for 5 years
Patients who are pregnant or lactating

Study is for people with:

Breast Cancer

Estimated Enrollment:

50

Study ID:

NCT00614172

Recruitment Status:

Completed

Sponsor:

Loma Linda University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Loma Linda University Medical Center / James M. Slater MD Proton Treatment Center / Department of Radiation Medicine / 11234 Anderson St.
Loma Linda California, 92354, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

50

Study ID:

NCT00614172

Recruitment Status:

Completed

Sponsor:


Loma Linda University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider